125 related articles for article (PubMed ID: 36111690)
21. Increased Sphingosine Kinase 1 Expression Is Associated with Poor Prognosis in Human Solid Tumors: A Meta-Analysis.
Zhang C; Zhou C; Xu J; Xue S
Dis Markers; 2022; 2022():8443932. PubMed ID: 35126792
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
[No Abstract] [Full Text] [Related]
23. The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis.
Li JZ; Gao W; Ho WK; Lei WB; Wei WI; Chan JY; Wong TS
Chin J Cancer; 2016 Nov; 35(1):95. PubMed ID: 27852288
[TBL] [Abstract][Full Text] [Related]
24. Krüppel-like factor 4 expression in solid tumor prognosis: A meta-analysis.
Yu M; Hao B; Zhan Y; Luo G
Clin Chim Acta; 2018 Oct; 485():50-59. PubMed ID: 29940144
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and prognostic significance of zinc finger antisense 1 overexpression in cancers: A meta-analysis.
Leng Y; Luo Q; Chen X; Chen F; Wang X; Pan Y
Medicine (Baltimore); 2018 Dec; 97(49):e13378. PubMed ID: 30544408
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological and prognostic value of SIRT6 in patients with solid tumors: a meta-analysis and TCGA data review.
Wu X; Wang S; Zhao X; Lai S; Yuan Z; Zhan Y; Ni K; Liu Z; Liu L; Xin R; Zhou X; Yin X; Liu X; Zhang X; Cui W; Zhang C
Cancer Cell Int; 2022 Feb; 22(1):84. PubMed ID: 35172823
[TBL] [Abstract][Full Text] [Related]
27. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
Wang J; Zhong P; Hua H
Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of long non-coding RNA H19 in various cancers: A meta-analysis based on 15 studies with 1584 patients and the Cancer Genome Atlas data.
Yu H; Li S; Wu SX; Huang S; Li S; Ye L
Medicine (Baltimore); 2020 Jan; 99(2):e18533. PubMed ID: 31914026
[TBL] [Abstract][Full Text] [Related]
29. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
30. Low NDRG2 expression predicts poor prognosis in solid tumors: A meta-analysis of cohort study.
Gu A; Xu J; Ye J; Zhang C
Medicine (Baltimore); 2020 Oct; 99(41):e22678. PubMed ID: 33031336
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of LINC00460 overexpression in solid tumours: a meta-analysis.
Dai C; Zhang Y; Ni H; Kuang Y; Xu Z
Postgrad Med J; 2020 May; 96(1135):286-295. PubMed ID: 32054779
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of indoleamine 2,3-dioxygenase 1 expression in solid tumors: A systematic review and meta-analysis.
Zhang H; Li J; Zhou Q
Front Oncol; 2022; 12():954495. PubMed ID: 36212460
[TBL] [Abstract][Full Text] [Related]
33. Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.
Liu J; Ma Q; Zhang M; Wang X; Zhang D; Li W; Wang F; Wu E
Eur J Cancer; 2012 Oct; 48(15):2328-38. PubMed ID: 22459764
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Zhang S; Qiu D; Xie X; Shen Y
BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
[TBL] [Abstract][Full Text] [Related]
35. Prognostic and clinicopathological significance of SR-B1 in solid tumors: A meta-analysis.
Wang M; Chao C; Luo G; Wang B; Zhan X; Di D; Qian Y; Zhang X
Pathol Res Pract; 2020 Apr; 216(4):152849. PubMed ID: 32057516
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis.
Cui X; Jia Z; Chen D; Xu C; Yang P
Medicine (Baltimore); 2020 Apr; 99(14):e19165. PubMed ID: 32243358
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis.
Zhang S; Liu W; Hu B; Wang P; Lv X; Chen S; Shao Z
Front Immunol; 2020; 11():1242. PubMed ID: 32714321
[No Abstract] [Full Text] [Related]
38. Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis.
Zeng P; Wang YH; Si M; Gu JH; Li P; Lu PH; Chen MB
Oncotarget; 2017 Jan; 8(3):5592-5602. PubMed ID: 27888619
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological and prognostic value of long noncoding RNA SNHG7 in cancers: a meta-analysis and bioinformatics.
Wang J; Du S; Wang C; Zhu Z; Xie B; Zhang B
Aging (Albany NY); 2021 Oct; 13(20):23796-23809. PubMed ID: 34714775
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of high FOXO3a expression in patients with solid tumors: A meta-analysis and systematic review.
Wang C; Tu X; Jiang Y; Jiao P; Deng X; Xie Y; Zhang L
Int J Biol Markers; 2022 Jun; 37(2):210-217. PubMed ID: 35484793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
